This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Structure of the human Estrogen Receptor Alpha (ERa) ligand-binding domain (LBD) Bound to A Family of Compounds with an Oxabicyclic Phenol Scaffold. We are working to determine the structures of ERa LBD complexed with a series of oxabicyclic phenol compounds in order to understand how their structures relate to their biological activity. Our interest in these structures is part of our structure-function characterization of the two known ER subtypes, ERa and ER Beta (ERb). We have previously determined structures of ER LBD complexes with various ligands that can act as full estrogen agonists, partial agonists/antagonists, or complete antagonists, depending on the tissue and target gene promoter context Our interest in the compounds with the oxabicyclic phenol scaffold stems from our discovery that they are ERb-selective partial agonists in our cell based transcriptional assays. We have very recently determined the structure of ERa in complex with one member of this family, OBCP (4-[5-(hydroxymethyl)-6,8,9-trimethyl-3-oxabicyclo[3.3.1]non-7-en-2-yl]phenol). We have several related compounds that differ from OBCP in that they contain, one or two, instead of three methyl groups in the core oxabicyclic scaffold. These compounds vary in their potency and selectivity for ERa and ERb. However, as the methyl groups do not appear to directly participate in binding key residues within the ER ligand binding pocket, it is unclear how they differ in their ability to promote ER agonism. Also, it is unclear how they are partial agonists of ERb. An improved understanding of how this family of compounds binds to ER will allow us to better use this scaffold for the development of improved subtype selective agonists and/or novel antagonists.
Weingarten, Adam S; Dannenhoffer, Adam J; Kazantsev, Roman V et al. (2018) Chromophore Dipole Directs Morphology and Photocatalytic Hydrogen Generation. J Am Chem Soc 140:4965-4968 |
Yang, Cheolhee; Choi, Minseo; Kim, Jong Goo et al. (2018) Protein Structural Dynamics of Wild-Type and Mutant Homodimeric Hemoglobin Studied by Time-Resolved X-Ray Solution Scattering. Int J Mol Sci 19: |
Kazantsev, Roman V; Dannenhoffer, Adam J; Weingarten, Adam S et al. (2017) Crystal-Phase Transitions and Photocatalysis in Supramolecular Scaffolds. J Am Chem Soc 139:6120-6127 |
Fournier, Bertrand; Sokolow, Jesse; Coppens, Philip (2016) Analysis of multicrystal pump-probe data sets. II. Scaling of ratio data sets. Acta Crystallogr A Found Adv 72:250-60 |
Cho, Hyun Sun; Schotte, Friedrich; Dashdorj, Naranbaatar et al. (2016) Picosecond Photobiology: Watching a Signaling Protein Function in Real Time via Time-Resolved Small- and Wide-Angle X-ray Scattering. J Am Chem Soc 138:8815-23 |
Pande, Kanupriya; Hutchison, Christopher D M; Groenhof, Gerrit et al. (2016) Femtosecond structural dynamics drives the trans/cis isomerization in photoactive yellow protein. Science 352:725-9 |
Weingarten, Adam S; Kazantsev, Roman V; Palmer, Liam C et al. (2015) Supramolecular Packing Controls H? Photocatalysis in Chromophore Amphiphile Hydrogels. J Am Chem Soc 137:15241-6 |
Pfoh, Roland; Pai, Emil F; Saridakis, Vivian (2015) Nicotinamide mononucleotide adenylyltransferase displays alternate binding modes for nicotinamide nucleotides. Acta Crystallogr D Biol Crystallogr 71:2032-9 |
Mariette, Céline; Guérin, Laurent; Rabiller, Philippe et al. (2015) The creation of modulated monoclinic aperiodic composites in n-alkane/urea compounds. Z Kristallogr Cryst Mater 230:5-11 |
Yang, Xiaojing; Stojkovi?, Emina A; Ozarowski, Wesley B et al. (2015) Light Signaling Mechanism of Two Tandem Bacteriophytochromes. Structure 23:1179-89 |
Showing the most recent 10 out of 120 publications